Novartis Pharmaceuticals Corporation | Novartis | North Carolina | state | 2011 | $31,277 | | tax credit/rebate |
Furiex Pharmaceuticals, Inc. | AbbVie | North Carolina | state | 2011 | $37,523 | | tax credit/rebate |
Novartis Animal Health US, Inc. | Novartis | North Carolina | state | 2011 | $62,613 | | tax credit/rebate |
Novozymes North America, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $78,340 | | tax credit/rebate |
Salix Pharmaceuticals, Inc. | Bausch Health | North Carolina | state | 2011 | $96,902 | | tax credit/rebate |
Purdue Pharma, LP | Purdue Pharma | North Carolina | state | 2011 | $123,488 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | North Carolina | state | 2011 | $158,503 | | tax credit/rebate |
Eisai, Inc. | Eisai | North Carolina | state | 2011 | $161,293 | | tax credit/rebate |
Wyeth Holdings Corporation | Pfizer | North Carolina | state | 2011 | $189,498 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2011 | $220,883 | | tax credit/rebate |
Novartis Vaccines & Diagnostics, Inc. | Novartis | North Carolina | state | 2011 | $318,349 | | tax credit/rebate |
United Therapeutics Corp | United Therapeutics | North Carolina | state | 2011 | $444,809 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2011 | $501,793 | | tax credit/rebate |
Gilead Sciences, Inc. | Gilead Sciences | North Carolina | state | 2011 | $550,523 | | tax credit/rebate |
GlaxoSmithkline Holdings Americas , Inc. | GlaxoSmithKline | North Carolina | state | 2011 | $4,039,279 | | tax credit/rebate |
Abbott Bioresearch Center, inc. | Abbott Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
Anika Therapeutics, Inc. | Anika Therapeutics | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | Massachusetts | state | 2006 | undisclosed | | tax credit/rebate |
DePuy Orthopaedics, Inc. | Johnson & Johnson | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
EMD Serono | Merck KGaA (EMD) | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
Epichem, Inc. | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
IDEXX Veterinary Services | IDEXX Laboratories | Massachusetts | state | 2002 | undisclosed | | tax credit/rebate |
PAREXEL International | Parexel International | Massachusetts | state | 2008 | undisclosed | | tax credit/rebate |
PAREXEL International Corp. | Parexel International | Massachusetts | state | 1998 | undisclosed | | tax credit/rebate |
Parexel International, LLC | Parexel International | Massachusetts | state | 2011 | $29,879 | | tax credit/rebate |
Serono Labs | Merck KGaA (EMD) | Massachusetts | state | 2001 | undisclosed | | tax credit/rebate |
Shire Human Genetics Therapies, Inc. | Takeda Pharmaceutical | Massachusetts | state | 2007 | undisclosed | | tax credit/rebate |
Vertex Pharmaceuticals Inc. | Vertex Pharmaceuticals | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
PAREXEL International Corporation | Parexel International | Massachusetts | state | 2011 | undisclosed | | tax credit/rebate |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | Mississippi | state | 2012 | $50,000 | | training reimbursement |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2005 | undisclosed | | tax credit/rebate |
Andrx Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | Florida | state | 2003 | undisclosed | | tax credit/rebate |
ANDRX Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 1998 | $815,500 | | tax credit/rebate |
Andrx Corporation, Inc. | Teva Pharmaceutical Industries | Florida | state | 2004 | $525,000 | | tax credit/rebate |
Bausch & Lomb Incorporated - Clearwater Facility | Bausch Health | Florida | state | 2005 | $135,000 | | tax credit/rebate |
Genzyme Corporation | Sanofi | Florida | state | 2010 | $524,000 | | tax credit/rebate |
Schering Corporation | Merck | Florida | state | 2007 | $84,000 | | tax credit/rebate |
Watson Laboratories, Inc. | Teva Pharmaceutical Industries | Florida | state | 2000 | $312,000 | | tax credit/rebate |
Genentech USA Inc. | Roche | Oregon | state | 2012 | $3,817,197 | | property tax abatement |
ALERE SCARBOROUGH, INC. | Abbott Laboratories | Maine | state | 2012 | $15,630 | | property tax abatement |
IDEXX LAB INC | IDEXX Laboratories | Maine | state | 2012 | $90,531 | | property tax abatement |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2012 | $90,160 | | property tax abatement |
IDEXX DISTRIBUTION INC | IDEXX Laboratories | Maine | state | 2012 | $1,623 | | property tax abatement |
Merck, Sharp & Dohme Corp. | Merck | Pennsylvania | state | 2012 | $10,263,039 | | tax credit/rebate |
Janssen Research & Development, LLC ( f/k/a J&J Pharmaceutical Research & Development, LLC) | Johnson & Johnson | Pennsylvania | state | 2012 | $5,461,142 | | tax credit/rebate |
GlaxoSmithKline, LLC ( f/k/a SmithKline Beecham Corporation) | GlaxoSmithKline | Pennsylvania | state | 2012 | $4,247,696 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | Pennsylvania | state | 2012 | $3,552,766 | | tax credit/rebate |
Forest Research Institute, Inc. | AbbVie | Pennsylvania | state | 2012 | $999,077 | | tax credit/rebate |
Teva Branded Pharmaceutical Products R&D, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $903,866 | | tax credit/rebate |
Endo Pharmaceuticals, Inc. | Endo International | Pennsylvania | state | 2012 | $454,512 | | tax credit/rebate |
CSL Behring, LLC | CSL Limited | Pennsylvania | state | 2012 | $342,911 | | tax credit/rebate |
Immunex Corporation | Amgen | Pennsylvania | state | 2012 | $297,513 | | tax credit/rebate |
Sanofi Pasteur, Inc. | Sanofi | Pennsylvania | state | 2012 | $162,846 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2012 | $160,814 | | tax credit/rebate |
Teva Pharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $129,362 | | tax credit/rebate |
Vitae Pharmaceuticals, Inc. (f/k/a Concurrent Pharmaceuticals, Inc.) | AbbVie | Pennsylvania | state | 2012 | $98,234 | | tax credit/rebate |
Ventana USA, LLP | Roche | Pennsylvania | state | 2012 | $28,896 | | tax credit/rebate |
Callidus Biopharma, Inc. | Amicus Therapeutics | Pennsylvania | state | 2012 | $24,402 | | tax credit/rebate |
NuPathe, Inc. | Teva Pharmaceutical Industries | Pennsylvania | state | 2012 | $12,593 | | tax credit/rebate |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | undisclosed | | training reimbursement |
AMYRIS, INC. | Amyris | California | state | 2012 | $99,927 | | training reimbursement |
ABBOTT VASCULAR, INC. | Abbott Laboratories | California | state | 2012 | $249,570 | | training reimbursement |
Endo Pharmaceuticals Valera, Inc. | Endo International | New Jersey | state | 2004 | $86,295 | | grant |
Innopharma Inc. | Pfizer | New Jersey | state | 2009 | $119,831 | | grant |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New Jersey | state | 2011 | $345,900 | | grant |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 1999 | $360,150 | | grant |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New Jersey | state | 2008 | $471,219 | | grant |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | New Jersey | state | 2011 | $569,910 | | grant |
Aptalis Pharma US, Inc. & Aptalis Pharmatech, Inc. | AbbVie | New Jersey | state | 2008 | $579,072 | | grant |
Chugai Pharma USA | Roche | New Jersey | state | 2004 | $582,225 | | grant |
Amneal Pharmaceuticals LLC | Amneal Pharmaceuticals | New Jersey | state | 2011 | $600,000 | | grant |
ImClone Systems Corporation | Eli Lilly | New Jersey | state | 1999 | $625,260 | | grant |
Perceptive Services, Inc. | Parexel International | New Jersey | state | 2005 | $685,125 | | grant |
Merck & Co., Inc. | Merck | New Jersey | state | 1999 | $874,000 | | grant |
Dava Pharmaceuticals, Inc. | Endo International | New Jersey | state | 2004 | $931,560 | | grant |
Forest Laboratories, Inc. and Forest Research | AbbVie | New Jersey | state | 2000 | $990,780 | | grant |
Dey Pharma, L.P., Mylan Inc. and Affiliates | Viatris | New Jersey | state | 2009 | $1,088,479 | | grant |
Eisai, Inc. and Eisai Corporation of North America | Eisai | New Jersey | state | 2005 | $1,203,750 | | grant |
Abbott Point of Care Inc. and Abbott Diabetes Care | Abbott Laboratories | New Jersey | state | 2008 | $1,218,244 | | grant |
Taro Pharmaceuticals U.S.A., Inc. | Sun Pharmaceuticals | New Jersey | state | 2003 | $1,287,195 | | grant |
Daiichi Sankyo, Inc. | Daiichi Sankyo | New Jersey | state | 2004 | $1,330,304 | | grant |
Dr. Reddy`s Laboratories | Dr. Reddy's Laboratories | New Jersey | state | 2010 | $1,364,220 | | grant |
Otsuka America Pharmaceutical, Inc. & Otsuka | Otsuka Pharmaceutical | New Jersey | state | 2009 | $1,449,375 | | grant |
Sandoz Inc. | Sandoz Group | New Jersey | state | 2002 | $1,866,487 | | grant |
Barr Laboratories, Inc. and Subsidiaries | Teva Pharmaceutical Industries | New Jersey | state | 2002 | $1,969,200 | | grant |
Sun Pharmaceutical Industries, Inc. | Sun Pharmaceuticals | New Jersey | state | 2008 | $2,382,217 | | grant |
ImClone Systems Corporation | Eli Lilly | New Jersey | state | 2001 | $2,755,200 | | grant |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. In | Sanofi | New Jersey | state | 1997 | $2,784,000 | | grant |
Watson Pharmaceuticals, Inc. and Affiliates | Teva Pharmaceutical Industries | New Jersey | state | 2009 | $3,038,000 | | grant |
Bausch & Lomb Incorporated | Bausch Health | New Jersey | state | 2008 | $3,500,000 | | grant |
Merck & Co. Inc. | Merck | New Jersey | state | 2000 | $3,948,650 | | grant |
Intervet Inc. | Merck | New Jersey | state | 2012 | $3,981,600 | | grant |
Bristol-Myers Squibb Company | Bristol-Myers Squibb | New Jersey | state | 1997 | $4,200,000 | | grant |
Valeant Pharmaceuticals North America LLC and | Bausch Health | New Jersey | state | 2003 | $4,325,100 | | grant |
NPS Pharmaceuticals, Inc. | Takeda Pharmaceutical | New Jersey | state | 2003 | $4,371,200 | | grant |
Amneal Pharmaceuticals LLC and Kashiv Pharma, LLC | Amneal Pharmaceuticals | New Jersey | state | 2010 | $4,638,000 | | grant |
Novo Nordisk, Inc. | Novo Holdings A/S | New Jersey | state | 2007 | $5,405,932 | | grant |
Novartis Pharmaceuticals Corporation ("NPC") | Novartis | New Jersey | state | 2004 | $5,822,250 | | grant |
Celgene Corporation | Bristol-Myers Squibb | New Jersey | state | 2004 | $6,086,250 | | grant |
King Pharmaceuticals, Inc. | Pfizer | New Jersey | state | 2005 | $8,253,750 | | grant |
Sanofi-Aventis U.S. LLC and Sanofi-Aventis U.S. | Sanofi | New Jersey | state | 2005 | $8,369,000 | | grant |